Topchoice Medical Investment Co., Inc. (SHSE:600763) signed the conditional assets acquisition agreement to acquire remaining 95.67% stake in Hangzhou Haijun Technology Co., Ltd. from 18 shareholders for CNY 4.4 billion on November 27, 2015. According to the agreement, Topchoice Medical Investment Co., Inc. will issue 79.72 million shares as consideration. The sellers include Hangzhou Aibo Holdings Co., Ltd., Zhejiang Cunji Medical Education Foundation, Wan Jiangang, Hangzhou Haijun Investment Management Partnership (Limited Partnership), Hangzhou Yiya Investment Management Partnership (Limited Partnership), Zhang Aoxing, Sun Zhangkang, Hangzhou Langen Investment Partnership (Limited Partnership), Hu Ai, Wen Lei, Jiang Xicai, Haining Sanren Runhao Equity Investment Partnership (Limited Partnership), Yu Hongying, Li Lianning, Pan Xiange, Li Jing, Yang Yichun and Xu Hang. Hangzhou Aibo Holdings Co., Ltd. will sell 64.95% stake and get 54.13 million shares, Zhejiang Cunji Medical Education Foundation will sell 8.66% stake and get 7.22 million shares, Wan Jiangang will sell 6.93% stake and get 5.8 million shares, Hangzhou Haijun Investment Management Partnership (Limited Partnership) will sell 1.67% stake and get 1.4 million shares, Hangzhou Yiya Investment Management Partnership (Limited Partnership) will sell 0.06% stake and get 0.05 million shares, Zhang Aoxing will sell 4.73% stake and get 3.9 million shares, Sun Zhangkang will sell 3.15% stake and get 2.63 million shares, Hangzhou Langen Investment Partnership (Limited Partnership) will sell 2.63% stake and get 2 million shares, Hu Ai will sell 1.58% stake and get 1.3 million shares, Wen Lei will sell 0.53% stake and get 0.44 million shares, Jiang Xicai will sell 0.32% stake and get 0.26 million shares, Haining Sanren Runhao Equity Investment Partnership (Limited Partnership) will sell 0.32% stake and get 0.26 million shares, Yu Hongying will sell 0.16% stake and get 0.13 million shares, Li Lianning will sell 0.1% stake and get 0.08 million shares, Pan Xiange will sell 0.08% stake and get 0.07 million shares, Li Jing will sell 0.03% stake and get 0.03 million shares, Yang Yichun will sell 0.03% stake and get 0.02 million shares and Xu Hang will sell 0.02% stake and get 0.02 million shares. Topchoice Medical Investment Co., Inc. intends to issue shares to not more than 10 specific investors to raise the matching funds of not more than CNY 550 million, the share issuance price will not be lower than CNY 81.94 per share, the number of shares to be issued will not be more than 6.71 million shares. As of December 31, 2014, Hangzhou Haijun Technology Co., Ltd’s total assets were CNY 96.85 million, total owners equity was CNY 56.95 million, revenue of CNY 0.20 million, operating loss of CNY 4.28 million and net loss of CNY 4.30 million. The lock up period of the shares subscribed by the not more than 10 specific investors is 12 months starting at the end of the share issuance date. The transaction is approved by the Board of Directors of Topchoice Medical Investment Co., Inc. The transaction is approved by approved by the shareholders’ of Hangzhou Aibo Holdings Co., Ltd., the related proposals of the major reorganization has been approved by Hangzhou Haijun Investment Management Partnership (Limited Partnership), Hangzhou Yiya Investment Management Partnership (Limited Partnership), Hangzhou Langen Investment Partnership (Limited Partnership), Haining Sanren Runhao Equity Investment Partnership (Limited Partnership).The transaction is approved by the shareholders’ meeting of Hangzhou Haijun Technology Co., Ltd. the transaction is subject to 2nd approval of the Board of Directors of Topchoice Medical Investment Co., Inc, the approval of the shareholders’ OF Topchoice Medical Investment Co., Inc., the approval of China Securities Regulatory Commission and other approval procedures possible needed. Ping An Securities Co., Ltd. acted as the independent financial advisor to Topchoice Medical Investment Co., Inc. Topchoice Medical Investment Co., Inc. (SHSE:600763) cancelled the acquisition of remaining 95.67% stake in Hangzhou Haijun Technology Co., Ltd. from 18 shareholders on May 20, 2016. The Directorate of Topchoice Medical Investment Co., Inc. approved the termination.